Healthcare provider profile · identity verified

Kurt R Crowe, M.D.

Emergency Medicine · AMBOY, IL · NPI 1831130129

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	987	250
Amlodipine Besylate	Amlodipine Besylate	498	120
Levothyroxine Sodium	Levothyroxine Sodium	493	110
Losartan Potassium	Losartan Potassium	472	115
Lisinopril	Lisinopril	451	111
Omeprazole	Omeprazole	444	113
Hydrochlorothiazide	Hydrochlorothiazide	399	95
Metoprolol Succinate	Metoprolol Succinate	355	96
Potassium Chloride	Potassium Chloride	333	81
Furosemide	Furosemide	312	77
Albuterol Sulfate Hfa	Albuterol Sulfate	283	81
Metformin Hcl Er	Metformin Hcl	279	75
Tamsulosin Hcl	Tamsulosin Hcl	279	68
Metoprolol Tartrate	Metoprolol Tartrate	269	68
Rosuvastatin Calcium	Rosuvastatin Calcium	259	79
Gabapentin	Gabapentin	254	48
Metformin Hcl	Metformin Hcl	237	70
Pantoprazole Sodium	Pantoprazole Sodium	228	54
Sertraline Hcl	Sertraline Hcl	219	43
Ozempic	Semaglutide	200	37
Escitalopram Oxalate	Escitalopram Oxalate	175	34
Trazodone Hcl	Trazodone Hcl	175	37
Tramadol Hcl	Tramadol Hcl	166	37
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	164	35
Methylprednisolone	Methylprednisolone	126	105
Clopidogrel	Clopidogrel Bisulfate	122	32
Citalopram Hbr	Citalopram Hydrobromide	116	20
Fluticasone Propionate	Fluticasone Propionate	108	31
Fluoxetine Hcl	Fluoxetine Hcl	104	18
Alprazolam	Alprazolam	103	30
Duloxetine Hcl	Duloxetine Hcl	101	22
Meloxicam	Meloxicam	100	30
Venlafaxine Hcl Er	Venlafaxine Hcl	99	18
Warfarin Sodium	Warfarin Sodium	97	suppressed
Allopurinol	Allopurinol	96	23
Simvastatin	Simvastatin	91	23
Cephalexin	Cephalexin	85	43
Montelukast Sodium	Montelukast Sodium	82	15
Alendronate Sodium	Alendronate Sodium	79	21
Glipizide Er	Glipizide	78	22
Eliquis	Apixaban	72	22
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	67	12
Trulicity	Dulaglutide	67	21
Ventolin Hfa	Albuterol Sulfate	66	16
Glipizide	Glipizide	64	18
Spironolactone	Spironolactone	63	17
Pravastatin Sodium	Pravastatin Sodium	58	14
Famotidine	Famotidine	56	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	54	12
Carvedilol	Carvedilol	52	11
Triamcinolone Acetonide	Triamcinolone Acetonide	52	19
Paroxetine Hcl	Paroxetine Hcl	51	12
Valacyclovir	Valacyclovir Hcl	51	11
Nystatin	Nystatin	50	25
Amitriptyline Hcl	Amitriptyline Hcl	49	suppressed
Mounjaro	Tirzepatide	48	17
Ezetimibe	Ezetimibe	46	11
Prednisone	Prednisone	46	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	45	19
Atenolol	Atenolol	44	12
Ondansetron Odt	Ondansetron	44	16
Mirtazapine	Mirtazapine	43	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	42	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	42	11
Nitroglycerin	Nitroglycerin	42	17
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	41	18
Novolog Flexpen	Insulin Aspart	40	suppressed
Benazepril Hcl	Benazepril Hcl	38	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	38	33
Comfort Ez Pen Needle	Pen Needle, Diabetic	36	suppressed
Finasteride	Finasteride	36	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	36	suppressed
Aripiprazole	Aripiprazole	35	suppressed
Pregabalin	Pregabalin	35	suppressed
Humalog Kwikpen U-100	Insulin Lispro	34	11
Farxiga	Dapagliflozin Propanediol	33	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	33	suppressed
Jardiance	Empagliflozin	33	suppressed
Memantine Hcl	Memantine Hcl	33	suppressed
Propranolol Hcl	Propranolol Hcl	33	suppressed
Symbicort	Budesonide/Formoterol Fumarate	33	suppressed
Amoxicillin	Amoxicillin	32	30
Baclofen	Baclofen	32	suppressed
Breo Ellipta	Fluticasone/Vilanterol	32	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	32	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	32	26
Lovastatin	Lovastatin	30	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Bupropion Hcl Sr	Bupropion Hcl	29	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	29	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	29	suppressed
Clonidine Hcl	Clonidine Hcl	28	suppressed
Lamotrigine	Lamotrigine	28	suppressed
Meclizine Hcl	Meclizine Hcl	28	16
Myrbetriq	Mirabegron	28	suppressed
Tiotropium Bromide	Tiotropium Bromide	28	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	27	25
Bupropion Xl	Bupropion Hcl	27	suppressed
Incruse Ellipta	Umeclidinium Bromide	27	suppressed
Ondansetron Hcl	Ondansetron Hcl	27	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	27	suppressed
Hydralazine Hcl	Hydralazine Hcl	25	suppressed
Levetiracetam	Levetiracetam	25	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	25	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	25	17
Terazosin Hcl	Terazosin Hcl	25	suppressed
Buspirone Hcl	Buspirone Hcl	24	suppressed
Lansoprazole	Lansoprazole	24	suppressed
Rizatriptan	Rizatriptan Benzoate	24	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	24	suppressed
Donepezil Hcl	Donepezil Hcl	23	suppressed
Fluconazole	Fluconazole	23	15
Xarelto	Rivaroxaban	23	suppressed
Azithromycin	Azithromycin	22	21
Januvia	Sitagliptin Phosphate	22	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	21	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	21	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	19	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	19	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Cilostazol	Cilostazol	18	suppressed
Clonazepam	Clonazepam	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	14
Topiramate	Topiramate	18	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Terbinafine Hcl	Terbinafine Hcl	17	suppressed
Ramipril	Ramipril	16	suppressed
Spiriva Handihaler	Tiotropium Bromide	16	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Eplerenone	Eplerenone	15	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	15	suppressed
Methimazole	Methimazole	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Celecoxib	Celecoxib	14	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	14	suppressed
Latanoprost	Latanoprost	14	suppressed
Potassium Citrate Er	Potassium Citrate	14	suppressed
Raloxifene Hcl	Raloxifene Hcl	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	13	suppressed
Digoxin	Digoxin	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	12	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	12	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Telmisartan	Telmisartan	12	suppressed
Trueplus Pen Needle	Pen Needle, Diabetic	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Bumetanide	Bumetanide	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Flovent Diskus	Fluticasone Propionate	11	suppressed
Nabumetone	Nabumetone	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error